Pregledni rad

https://doi.org/10.37797/ig.40.4.4

Coronavirus Disease 19 (COVID-19) Pharmacologic Treatment: Where Are We Now?

Nikolina Bogdanić orcid.org/0000-0002-7921-2721 ; University Hospital for Infectious Diseases “Dr. Fran Mihaljević”, Zagreb, Croatia
Ljiljana Lukić orcid.org/0000-0002-6216-2078 ; University Hospital for Infectious Diseases “Dr. Fran Mihaljević”, Zagreb, Croatia
Josip Begovac ; University Hospital for Infectious Diseases “Dr. Fran Mihaljević”, Zagreb, Croatia; School of Medicine, University of Zagreb, Croatia

Sažetak

Since the first cases of COVID-19 were reported from China the disease became pandemic within a few months. The viral genome was sequenced soon after the outbreak of COVID-19 which enabled development of diagnostic tests and therapeutic options. As the knowledge of SARS-CoV-2 virology increased, many potential drugs appeared. At this moment (January 12th 2021), 4426 studies of COVID-19 are registered, and more than 2680 studies are investigating therapeutic options. This is a short narrative review of currently available evidence on pharmacological treatment of COVID-19.

Ključne riječi

COVID-19; SARS-CoV-2; treatment

Hrčak ID:

254022

URI

https://hrcak.srce.hr/254022

Datum izdavanja:

18.3.2021.

Podaci na drugim jezicima: hrvatski

Posjeta: 2.105 *